Alleviant Medical
ApprovedAlleviant Medical's interatrial shunt therapy without an implant is currently being evaluated in heart failure patients. FDA approved clinical trial programs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $115.7M
About
Alleviant Medical's interatrial shunt therapy without an implant is currently being evaluated in heart failure patients. FDA approved clinical trial programs.
CardiovascularMedical Devices
Funding History
9Total raised:$115.7M
Grant$499KSep 17, 2024
Grant$998KJan 15, 2024
Grant$1.0MFeb 28, 2023
Series B$25MJul 15, 2022